BioCrossroads CEO bullish on Lilly’s latest LEAP commitment
The CEO of BioCrossroads says Eli Lilly and Co.'s latest multibillion-dollar investment in the LEAP Lebanon Innovation District is tremendous for the state's life sciences ecosystem. Vince Wong told IIB that the benefits of Lilly's investment is twofold.... Read More